Scarring Alopecia (FFA) Clinical Trial
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia Click HERE to learn more about this open trial.
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia Click HERE to learn more about this open trial.
Click HERE to view the report
Thank you to everyone who participated in the survey series. We had over 300 members answering each of the four surveys and sharing input, ideas, and personal advice. The office is busy summarizing the information to build CARF’s future strategic plan, but we wanted to share just a few snippets of what we’ve learned so far. [...]
Learning I have this crazy thing called frontal fibrosing alopecia (FFA) left me feeling both numb with grief yet mysteriously relieved. By the time I was diagnosed in the summer of 2016, I had already run the gamut of hair camouflage techniques and futile attempts to get my hair to start growing again. Extensive Google searches [...]
By Loren Krueger, MD March 2019 Frontal fibrosing alopecia, or FFA, is a scarring form of hair loss that commonly occurs at the frontal and temporal hairlines. Its incidence is increasing. As we learn more about FFA, we are beginning to identify additional skin and hair findings that are associated with FFA. FFA may involve loss [...]